LILLY ENDOWMENT INCLILLY ENDOWMENT INC

Institutional investor · Portfolio as of Q3 2023

Top Holdings1 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

ELI LILLY & CO

100M$53.7B100.0%$118.12+345.45%
19 qtrssince 2019-Q1
Decreased
0
$53.7B
AUM
1
Positions
Q3 2023
Filing
2.0/5
HI score
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q3'23
New0%Increased0%Decreased100%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.5 years
<1Q0%1-4Q0%1-2Y0%2Y+100%

LILLY ENDOWMENT INC manages $53.7B across 1 positions as of Q3 2023. Top holdings: LLY (100.0%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2/5.0.

Q3 2023 Summary

Trimmed 1. No standout high-conviction moves this quarter. Portfolio: $53.7B across 1 positions.

Top holdings by portfolio weight

Total AUM$54B
LLY100.00%

Portfolio allocation by GICS sector

Sectors1
Healthcare100.00%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&LNo data
Conviction34
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used